A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis

Published: 11 February 2022| Version 1 | DOI: 10.17632/pftdvts575.1
Contributor:

Description

data used in figures and tables from paper Sci Rep . 2021 Feb 18;11(1):4063. doi: 10.1038/s41598-021-83543-z. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis Alexander Lind # 1 , Ilaria Marzinotto # 2 , Cristina Brigatti 2 , Anita Ramelius 1 , Lorenzo Piemonti 2 , Vito Lampasona 3 Affiliations 1 Department of Clinical Sciences, Clinical Research Center (CRC), Skåne University Hospital SUS, Lund University, Malmö, Sweden. 2 San Raffaele Diabetes Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. 3 San Raffaele Diabetes Research Institute, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. lampasona.vito@hsr.it. # Contributed equally. PMID: 33603024 PMCID: PMC7893011 DOI: 10.1038/s41598-021-83543-z

Files

Steps to reproduce

R code is available upon reasonable request

Institutions

Ospedale San Raffaele

Categories

Biomarkers, Autoimmunity, Influenza, Immunoprecipitation, Antibody, Immunoassay, Narcolepsy

Licence